{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:52:02Z","timestamp":1791395522384,"version":"4.3.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CVIR Endovasc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study aimed to determine the safety and effectiveness of uterine artery embolization using NBCA \u2013 lipiodol mixture via radial artery access for the treatment of uterine fibroids.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Forty patients underwent uterine artery embolization with NBCA mixed with lipiodol (1:10). The uterine fibroid volumes were determined on magnetic resonance imaging before and 3\u20136\u00a0months after the procedure. We analyzed the following parameters: dominant fibroid volume, hemoglobin levels, symptoms before treatment, after embolization, and complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean age was 41\u2009\u00b1\u20096.5\u00a0years and mean uterine volume prior to treatment, 137.7\u2009\u00b1\u2009104.3\u00a0ml. After 3\u20136\u00a0months embolization, the mean fibroid volume decreased from 137.7\u2009\u00b1\u2009104.3 cm\n                      <jats:sup>3<\/jats:sup>\n                      to 51\u2009\u00b1\u200954.3 cm\n                      <jats:sup>3<\/jats:sup>\n                      (p\u2009&lt;\u20090.001), corresponding to a mean volume reduction of 64.7\u2009\u00b1\u200922.7%. Hemoglobin levels also significantly increased (p\u2009&lt;\u20090.001). No major intraprocedural adverse events were observed. Major complications occurred in 2.5% (fibroid expulsion). The minor complications rate was 20%, related to post-embolization syndrome (pain). The late adverse events occurred in 10%: alopecia (7.5%), vaginal dryness (2.5%). The length of hospital stay was 1.9\u2009\u00b1\u20090.8\u00a0days. Clinical symptomatic improvement was observed in 100% and symptoms were resolved in 87.5%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This prospective single-arm study suggests that UAE using a diluted NBCA\u2013lipiodol mixture is feasible and appears to be safe, with encouraging early clinical and MRI outcomes. However, the short follow-up period, absence of a comparative control group, and lack of direct assessment of fibroid infarction preclude definitive conclusions regarding its efficacy or its role relative to established particulate embolic agents.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42155-026-00782-9","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:25:56Z","timestamp":1791347156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prospective evaluation of uterine artery embolization using diluted NBCA-lipiodol mixture for uterine fibroids: preliminary treatment outcomes"],"prefix":"10.1186","volume":"9","author":[{"given":"Nguyen Thi Bich","family":"Van","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thanh","family":"Khiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8809-9583","authenticated-orcid":false,"given":"Nguyen Ngoc","family":"Cuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phan Hoang","family":"Giang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Quang","family":"Trung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thieu Thi Tra","family":"My","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bui Thi Phuong","family":"Thao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Quoc","family":"Hoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"issue":"1143","key":"782_CR1","doi-asserted-by":"publisher","first-page":"20220121","DOI":"10.1259\/bjr.20220121","volume":"96","author":"T Kr\u00f6ncke","year":"2023","unstructured":"Kr\u00f6ncke T. An update on uterine artery embolization for uterine leiomyomata and adenomyosis of the uterus. BJR. 2023;96(1143):20220121.","journal-title":"BJR"},{"issue":"8","key":"782_CR2","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1111\/aogs.15165","volume":"104","author":"LM Trommelen","year":"2025","unstructured":"Trommelen LM, Semmler A, de Bruijn AM, Harmsen M, Smink M, Janssen PF, et al. Quality of life 1 year after uterine artery embolization vs hysterectomy for symptomatic adenomyosis (QUESTA study). Acta Obstet Gynecol Scand. 2025;104(8):1558\u201374.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"782_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4274\/tjod.galenos.2023.43778","volume":"20","author":"AA Sofy","year":"2023","unstructured":"Sofy AA, Tsui S. Comparison of polyvinyl alcohol particles and trisacryl gelatin microspheres embolic agents used in uterine artery embolization: a systematic review and meta-analysis. J Turk Soc Obstet Gynecol. 2023;20(1):74\u201384.","journal-title":"J Turk Soc Obstet Gynecol"},{"issue":"04","key":"782_CR4","doi-asserted-by":"publisher","first-page":"488","DOI":"10.4103\/ijri.IJRI_204_16","volume":"27","author":"CJ Das","year":"2017","unstructured":"Das CJ, Rathinam D, Manchanda S, Srivastava DN. Endovascular uterine artery interventions. Indian J Radiol Imaging. 2017;27(04):488\u201395.","journal-title":"Indian J Radiol Imaging"},{"issue":"5","key":"782_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/gels9050378","volume":"9","author":"A Pal","year":"2023","unstructured":"Pal A, Blanzy J, G\u00f3mez KJR, Preul MC, Vernon BL. Liquid embolic agents for endovascular embolization: a review. Gels. 2023;9(5):378.","journal-title":"Gels"},{"key":"782_CR6","doi-asserted-by":"publisher","unstructured":"Chen LK, Yang BL, Chen KC, Tsai YL. Successful transarterial embolization of uterine arteriovenous malformation: report of three cases. Iran J Radiol. 2016;13(1). https:\/\/doi.org\/10.5812\/iranjradiol.15358","DOI":"10.5812\/iranjradiol.15358"},{"issue":"1169","key":"782_CR7","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/bjr\/tqaf036","volume":"98","author":"W Clements","year":"2025","unstructured":"Clements W, Lukies MW, Coleman M, et al. PREDICTing post-embolization syndrome after uterine fibroid embolization: the PREDICT-PES study. Br J Radiol. 2025;98(1169):709\u201314.","journal-title":"Br J Radiol"},{"issue":"8976","key":"782_CR8","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0140-6736(95)92282-2","volume":"346","author":"JH Ravina","year":"1995","unstructured":"Ravina JH, Ciraru-Vigneron N, Bouret JM, Bouret JM, Houdart E, Aymard A, et al. Arterial embolisation to treat uterine myomata. The Lancet. 1995;346(8976):671\u20132.","journal-title":"The Lancet"},{"issue":"4","key":"782_CR9","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1056\/NEJMoa062003","volume":"356","author":"RD Edwards","year":"2007","unstructured":"Edwards RD, Moss JG, Lumsden MA, Wu O, Murray LS, Twaddle S, et al. Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N Engl J Med. 2007;356(4):360\u201370.","journal-title":"N Engl J Med"},{"issue":"4","key":"782_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.5114\/pm.2014.45001","volume":"13","author":"P Czuczwar","year":"2014","unstructured":"Czuczwar P, Wo\u017aniak S, Szkodziak P, Wo\u017aniakowska E, Paszkowski M, Wrona W, et al. Predicting the results of uterine artery embolization: correlation between initial intramural fibroid volume and percentage volume decrease. Przeglad menopauzalny = Menopause review. 2014;13(4):247\u201352.","journal-title":"Przeglad menopauzalny = Menopause review"},{"issue":"4","key":"782_CR11","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jvir.2009.12.388","volume":"21","author":"NNN Naguib","year":"2010","unstructured":"Naguib NNN, Mbalisike E, Nour-Eldin NEA, Jost A, Lehnert T, Ackermann H, et al. Leiomyoma Volume Changes at Follow-up after Uterine Artery Embolization: Correlation with the Initial Leiomyoma Volume and Location. J Vasc Interv Radiol. 2010;21(4):490\u20135.","journal-title":"J Vasc Interv Radiol"},{"issue":"5","key":"782_CR12","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1590\/S0100-69912013000500007","volume":"40","author":"J Ghiaroni","year":"2013","unstructured":"Ghiaroni J, Lopez GE, Coutinho Junior AC, Schanaider A. Emboliza\u00e7\u00e3o das art\u00e9rias uterinas com part\u00edculas de PVA-PVAC esf\u00e9rico como preparo para posterior ressec\u00e7\u00e3o cir\u00fargica de miomas. Rev Col Bras Cir. 2013;40(5):386\u201391. https:\/\/doi.org\/10.1590\/S0100-69912013000500007.","journal-title":"Rev Col Bras Cir"},{"issue":"1","key":"782_CR13","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.5797\/jnet.ra.2024-0055","volume":"19","author":"N Kidani","year":"2025","unstructured":"Kidani N, Hirotsune N. NBCA: Basic Knowledge. Noushinkei Kekkannai Tiryou. 2025;19(1):2024\u20130055.","journal-title":"Noushinkei Kekkannai Tiryou."},{"issue":"1","key":"782_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00062-021-01066-6","volume":"32","author":"DF Vollherbst","year":"2022","unstructured":"Vollherbst DF, Chapot R, Bendszus M, M\u00f6hlenbruch MA. Glue, onyx, squid or PHIL? Liquid embolic agents for the embolization of cerebral arteriovenous malformations and dural arteriovenous fistulas. Clin Neuroradiol. 2022;32(1):25\u201338.","journal-title":"Clin Neuroradiol"},{"issue":"19","key":"782_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10194320","volume":"10","author":"PO Comby","year":"2021","unstructured":"Comby PO, Guillen K, Chevallier O, Lenfant M, Pellegrinelli J, Falvo N, et al. Endovascular use of cyanoacrylate-lipiodol mixture for peripheral embolization: properties, techniques, pitfalls, and applications. J Clin Med. 2021;10(19):4320.","journal-title":"J Clin Med"},{"issue":"5","key":"782_CR16","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.2214\/AJR.11.8362","volume":"199","author":"SS Toor","year":"2012","unstructured":"Toor SS, Jaberi A, Macdonald DB, McInnes MDF, Schweitzer ME, Rasuli P. Complication rates and effectiveness of uterine artery embolization in the treatment of symptomatic leiomyomas: a systematic review and meta-analysis. AJR Am J Roentgenol. 2012;199(5):1153\u201363.","journal-title":"AJR Am J Roentgenol"},{"issue":"7","key":"782_CR17","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.clinthera.2017.05.346","volume":"39","author":"MCM Fonseca","year":"2017","unstructured":"Fonseca MCM, Castro R, Machado M, Conte T, Girao MJBC. Uterine Artery Embolization and Surgical Methods for the Treatment of Symptomatic Uterine Leiomyomas: A Systemic Review and Meta-analysis Followed by Indirect Treatment Comparison. Clin Ther. 2017;39(7):1438-1455.e2.","journal-title":"Clin Ther"},{"issue":"11","key":"782_CR18","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1046\/j.1471-0528.2002.01449.x","volume":"109","author":"WJ Walker","year":"2002","unstructured":"Walker WJ, Pelage JP. Uterine artery embolisation for symptomatic fibroids: clinical results in 400 women with imaging follow up. BJOG. 2002;109(11):1262\u201372.","journal-title":"BJOG"},{"issue":"11","key":"782_CR19","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.jvir.2011.08.004","volume":"22","author":"RD Shlansky-Goldberg","year":"2011","unstructured":"Shlansky-Goldberg RD, Coryell L, Stavropoulos SW, Trerotola SO, Mondschein J, Beshara M, et al. Outcomes Following Fibroid Expulsion after Uterine Artery Embolization. J Vasc Interv Radiol. 2011;22(11):1586\u201393.","journal-title":"J Vasc Interv Radiol"},{"issue":"3","key":"782_CR20","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1148\/radiol.2303030111","volume":"230","author":"JP Pelage","year":"2004","unstructured":"Pelage JP, Guaou NG, Jha RC, Ascher SM, Spies JB. Uterine fibroid tumors: long-term MR imaging outcome after embolization. Radiology. 2004;230(3):803\u20139.","journal-title":"Radiology"}],"container-title":["CVIR Endovascular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42155-026-00782-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42155-026-00782-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42155-026-00782-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:02:07Z","timestamp":1791392527000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42155-026-00782-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["782"],"URL":"https:\/\/doi.org\/10.1186\/s42155-026-00782-9","relation":{},"ISSN":["2520-8934"],"issn-type":[{"value":"2520-8934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"6 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the institutional ethics committee of Hanoi Medical University Hospital. Written informed consent was obtained from all participants prior to inclusion in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"128"}}